Crossmark

High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status

Published Online: 2019-09-03

Published Print: 2019-12

Authors

Kortekaas, Kim E.

Santegoets, Saskia J.

Abdulrahman, Ziena

van Ham, Vanessa J.

van der Tol, Marij

Ehsan, Ilina

van Doorn, Helena C.

Bosse, Tjalling

van Poelgeest, Mariëtte I. E.

van der Burg, Sjoerd H. https://orcid.org/0000-0002-6556-0354
Funding

Funding for this research was provided by:

KWF Kankerbestrijding (2016-10168)
License Information

Text and Data Mining valid from 2019-09-03
More Information

Article History

Received: 28 May 2019

Accepted: 16 August 2019

First Online: 3 September 2019

Ethics approval and consent to participate

: The study was conducted in accordance with the Declaration of Helsinki and approved by the local medical ethical committee of the Leiden University Medical Center (P08.197 and B16.024) and in agreement with the Dutch law. The materials were used according to the Dutch Federation of Medical Research Association guidelines.

: Not applicable

: The authors declare that they have no competing interests.

Document is current